UBS Group
CNXU

UBS Group’s Conexeu Sciences Inc CNXU Stock Holding History

UBS Group’s Portfolio CNXU Stock Details CNXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
+12,264
New +$158K ﹤0.01% 7019

Other funds holding CNXU

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

UBS Group's CNXU Position: Q2 2026 in Review

UBS Group opened a new position in Conexeu Sciences Inc (CNXU) in Q2 2026: 12,264 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #7019 among its holdings.

6 funds tracked by Wall St. Rank hold CNXU as of Q2 2026.

  • UBS Group held 12,264 shares of Conexeu Sciences Inc worth $134K as of Q2 2026.
  • Conexeu Sciences Inc was a new UBS Group position in Q2 2026.
  • Conexeu Sciences Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7019 holding.
  • 6 funds tracked by Wall St. Rank held Conexeu Sciences Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.